tiprankstipranks

Gilla Kaplan Insider Profile

4 Followers
Gilla Kaplan, Director at Celgene, holds 76.30K shares in Celgene (Ticker: CELG), holds ― shares in Avalo Therapeutics (Ticker: AVTX), holds 89.62K shares in Tyra Bioscience (Ticker: TYRA). Most recently, Gilla Kaplan Sold ― shares of Celgene on Aug 03, 2017 for an estimated value of 1.01M.
tipranks
Gilla Kaplan

Gilla Kaplan
Celgene (CELG)
Director

Ranked #14,370 out of 99,635 Corporate Insiders

Profitable Transactions

86%
6 out of 7 Profitable Transactions

Average Return

+15.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
0.00%
A breakdown of Gilla Kaplan's holdings

Insider Roles

Tyra Bioscience
(TYRA)
Director
Avalo Therapeutics
(AVTX)
Director
Roles that Gilla Kaplan holds in companies

Most Profitable Insider Trade

Stock:
Celgene
(CELG)
Rating:Informative Buy
Date:Feb 14, 2014 - Feb 14, 2015
Return:+41.30%
The most profitable trade made by Gilla Kaplan

Gilla Kaplan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CELG
Celgene
Aug 03, 2017
Informative Sell
1.01M
$8.26M
Avalo Therapeutics
Director
Tyra Bioscience
Jun 18, 2024
Director
Uninformative Buy
37.45K
$1.45M
List of latest transactions for each holding click on a transaction to see Gilla Kaplan's performance on stock

Gilla Kaplan insider profile FAQ

What is the percentage of profitable transactions made by Gilla Kaplan?
The percentage of profitable transactions made by Gilla Kaplan is 86%.
    What is the average return per transaction made by Gilla Kaplan?
    The average return per transaction made by Gilla Kaplan is 15.40%.
      What stocks does Gilla Kaplan hold?
      Gilla Kaplan holds: CELG, AVTX, TYRA stocks.
        What was Gilla Kaplan’s latest transaction?
        Gilla Kaplan latest transaction was an Informative Sell of $1.01M.
          What was Gilla Kaplan's most profitable transaction?
          Gilla Kaplan’s most profitable transaction was an Informative Buy of CELG stock on February 14, 2014. The return on the trade was 41.30%.
            What is Gilla Kaplan's role in Celgene?
            Gilla Kaplan's role in Celgene is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.